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Abstract:  
Objective: To investigate the validity and reliability of the EuroQol (EQ-5D), the Short form health survey 
(SF-12v2), and the Hospital Anxiety and Depression Scale (HADS) in a stable coronary population. 
Study Design: Cross-sectional study EUROPASPIRE III 
Setting: Quality of Life data (Qol) were available on 8745 patients hospitalized for coronary artery bypass 
graft (CABG), percutaneous coronary intervention (PCI) or acute myocardial infarction (AMI). They were 
interviewed and examined at least 6 months after their hospital admission. Reliability and validity of the 
3 instruments were tested. Internal consistency, and discriminative, convergent, criterion and construct 
validity were assessed. 
Results: Cronbach’s alpha indicated good internal consistency for all measures (0.73 to 0.87). 
Discriminative validity analyses confirmed significant QoL differences between known groups: age, 
gender, educational level. In addition, all hypothesized correlations between QoL constructs (convergent 
validity) and items (criterion validity) were confirmed with significant correlations. Confirmatory factor 
analyses indicated good construct validity for HADS and SF-12v2. On country-specific level, results were 
roughly similar. 
Conclusion: The EQ-5D as well as the SF-12v2 and the HADS are reliable and valid instruments for use in 
a stable coronary population, both on aggregate European level as on country-specific level. However, 
our results must be generalized with caution, because EUROASPIRE III patients might not be 
representative for all patients with stable coronary heart disease. 
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Introduction 
Due to improved cardiovascular prevention and management, Coronary Heart Disease (CHD) death rates 
have decreased in Western, Northern, and Southern European countries during the last decades (1;2). 
Despite this reduction, CHD remains the most common cause of disease burden throughout Europe. 
Conventional medicine focuses mainly on clinical measures and functional outcomes, however the use of 
health related Quality of Life (QoL) instruments has become increasingly important to assess the 
patient’s emotional, social and physical well-being (3;4). Patients suffering from CHD are likely to have an 
impaired QoL, due to pain, anxiety, functional and social limitations (5-8). Although still under debate, 
several studies have observed a relationship between QoL, depression, anxiety and worse long-term 
health outcomes (9-13). Many QoL measures are available, and most of them have been 
comprehensively tested in the general population with regard to their reliability and validity. In addition, 
different studies have assessed the psychometric properties of QoL instruments in various disease-
specific samples, including CHD patients; however in general, cross-European data were limited (14-17).  
Within the EUROASPIRE III programme (EUROpean Action on Secondary and Primary Prevention through 
Intervention to Reduce Events), a multicentre European survey developed to assess how clinical 
guidelines on cardiovascular disease prevention are implemented throughout Europe, QoL assessment 
was performed on the basis of 3 questionnaires: the EuroQol-5D (EQ-5D) (18;19), the 12-item Short-
Form Health Survey (SF-12v2) (20), and the Hospital Anxiety and Depression Scales (HADS) (21). 
EQ-5D is a widely used simple, generic instrument to measure health in a standardized way. The 
measure is applicable to a wide range of conditions and treatments and contains a self-classifier and a 
visual analogue scale. Based on the self-classifier, a single index value can be calculated, representing the 
overall health status (19;22). Another commonly used health status questionnaire is the SF-12, a 
downsized version of the SF-36 and therefore useful for large studies. The measure allows to calculate a 
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Physical Component Summary (PCS-12) score and a Mental Component Summary (MCS-12) score (20). In 
addition to these general health measures, specific instruments are available for assessing anxiety, 
depression or depressive symptoms; feelings that are highly common in coronary patients (7;11). In 
order to adapt treatment accordingly, screening for depressive feelings and anxiety is important. The 
HADS instrument permits to calculate both an anxiety (HADS-A) and a depression (HADS-D) score.  
The present study investigates the psychometric properties of the EQ-5D, SF-12 and HADS instruments in 
a large multi-country European cross-sectional sample of coronary patients, the EUROASPIRE III survey. 
Methods 
Study population and data collection 
Analyses were based on data gathered during the EUROASPIRE III survey. The details of the study have 
been reported elsewhere (23). In brief, EUROASPIRE III, performed in 2006-2007 among patients with 
established CHD, is a cross-sectional study aimed at determining whether the European 
recommendations of cardiovascular disease prevention are being followed in daily practice. Patients, 
aged 80 years or less, hospitalized for coronary artery bypass graft (CABG), percutaneous coronary 
intervention (PCI), acute myocardial infarction (AMI) or myocardial ischemia were retrospectively 
identified from diagnostic registers, hospital discharge lists or other sources at 76 different hospital 
centres in 22 European countries: Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Finland, France, 
Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Poland, Romania, Russia, Slovenia, Spain, The 
Netherlands, Turkey, and the United Kingdom (UK). Data collection was conducted by trained research 
staff using standardized methods and instruments. Of the 13,935 patients identified, 8,966 were 
interviewed and examined at least 6 months and not later than 3 years after their index hospital 
admission.  
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In addition to the collection of disease related clinical measures, patients were asked to fill in 3 self-
administered questionnaires related to QoL and perceived overall health status: EQ-5D, HADS and SF-
12v2. In each country, questionnaires were administered in the official language. EQ-5D contains a self 
classifier (EQ-5Dindex) and a visual analogue scale (EQ-VAS). The former is made up of five likert-scale 
items covering the following dimensions: mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression. A single summary index, according to the weighting system derived by Dolan et al 
(1997) is derived from the answers given on the self-classifier; with 1 representing perfect health, 0 
representing death, and <0 representing a health state perceived worse than death (22;24). The EQ-VAS 
is a 20-cm vertical scale, ranging between 0 (worst imaginable health state) and 100 (best imaginable 
health state) on which the respondent is asked to indicate how good or bad his or her health is today.  
The SF-12v2 exists of 12 questions, with 3 to 5 response levels, and is intended to asses both physical 
and mental functioning, represented by a Physical Component Summary (PCS-12) score and a Mental 
Component Summary (MCS-12) score respectively.  The PCS-12 and MCS-12 scores were calculated 
based on a US general population scoring algorithm (25). Results are represented by a value ranging 
between 0 and 100, with 0 representing the lowest level of health and 100 the highest level of health. 
The SF-12v2 was not administered in Hungary. In Germany, the SF-36 was used instead of the SF-12v2,  
however an overall physical and mental component score could be calculated using the SF-12 items 
embedded in the SF-36.  
The HADS, intended for use in a hospital setting, contains 14 items, each with a four-point response scale. 
Seven items are related to anxiety and the other 7 items to depression. The instrument gives information 
about possible or probable anxiety or depressive feelings, but is not appropriate to screen for clinical 
depression. Item scores can be added to obtain the summary scores on anxiety (HADS-A) and depression 
(HADS-D) separately. The total score on each subscale ranges between 0 and 21. A score < 8 can be 
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considered as being in the normal range, higher scores can indicate a possible or probable disorder 
(21;26). 
Psychometric analyses 
Psychometrics aims to evaluate the reliability and validity of measures by assessing the characteristics of 
scales (27). Stratification by country, gender, age and educational level was performed. Four age groups 
were considered: <50 year, 50-59 years, 60-69 years and >70 years. And 3 educational levels were used: 
primary education, defined as primary school or less; secondary education, defined as secondary school 
completed, high school completed or intermediate between secondary level completed; and high 
education, defined as a university/college degree or equivalent. Patient records for which no summary 
score could be calculated were excluded from the analyses. 
Reliability 
Internal consistency of the EQ-5D self-classifier, PCS-12, MCS-12, HADS-A and HADS-D was examined 
using the Cronbach’s coefficient alpha (27). A threshold of 0.7 was considered acceptable, a value >0.8 
good, >0.9 indicated excellent internal consistency (28).  
Validity 
Confirmatory factor analysis (CFA) for the SF-12 and HADS measures was conducted in order to test 
whether the original scale construct was confirmed in this sample. No CFA was performed for EQ-5D 
since this measure does not include different theoretical constructs. The Weighted Least Squares Means 
and Variance adjusted (WLSMV) estimation method was used for ordinal data. Multiple goodness of fit 
tests were used, including the Root mean Square Error of Approximation (RMSEA), the Comparative Fit 
Index (CFI) and the Tucker-Lewis Index (TLI).  Since it is well known that the overall χ2 fit index is largely 
influenced by sample size, tending to over-reject models with large sample size, this index was not used 
in drawing conclusions (29). For CFI and TLI, a threshold value >0.9 was considered as a good fit (30). 
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Whereas for the RMSEA, a value <0.06 was considered as a good fit, a value <0.08 was considered as an 
acceptable fit and a value >0.1 led to rejection of the model (29;31). Factor loadings represent the 
correlation between observed variables and extracted components. Standardized factor loadings >0.5 
were perceived as good, loading >0.4 indicated an acceptable correlation and those <0.4 were perceived 
as not good.  
Discriminative validity was examined with the known-group method by assessing the relationship of the 
QoL constructs with age, gender and education. Non-parametric tests (Kruskall-Wallis) were used due to 
the skewed nature of data. We hypothesized that QoL would decrease with age and lower education, 
and would be lower in female patients. 
Convergent validity was evaluated with the Spearman correlations for theoretically correlated constructs.  
Constructs capturing similar functional or emotional characteristics were expected to highly correlate 
with one another. Correlations <0.3 were considered as negligible, a value between 0.3 and 0.5 as 
moderate and >0.5  as strong (32). It was hypothesized that MCS-12 would correlate with HADS-A and 
HADS-D and that the two HADS-scales would correlate with each other. Furthermore, it was expected 
that the EQ-5Dindex  correlates with PCS-12 and MCS-12.  
In addition, the EQ-VAS was considered as criterion for overall health, hence a correlation between EQ-
VAS and PCS-12, MCS-12 and EQ-5Dindex was expected. Likewise, the first question of the SF-12v2 
instrument (SF12-1), asking about the general state of an individual’s health, was also considered as a 
criterion of overall health. The SF12-1 was hypothesized to correlate with EQ-5Dindex and the EQ-VAS. 
Similarly the EQ-5D anxiety/depression item and question 6c of the SF-12 item “Have you felt 
downhearted and depressed?” were considered as an overall criterion for anxiety and depression. 
Therefore these items were expected to correlate with both HADS-A and HADS-D.  
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All analyses were performed using IBM SPSS 19, except the CFA, which was conducted using M-plus 
version 6.11.  
Results 
General characteristics 
The patient characteristics are presented in table 1. In total, data on 8,745 patients from 22 European 
countries are included in the psychometric analyses, ranging from 120 Greek patients to 550 patients 
from Germany. The majority of patients were male (74.6%) and their mean age was 63.2 +/-9.5 years. 
Regarding educational level, about a quarter (25.3%) of the patients had a primary education. More than 
half (56.7%) of the patients had a secondary education and 18.0% had a higher education.  
[insert table 1 somewhere here] 
Mean values of the different QoL scales and subscales are shown in table 2. Intraclass correlation 
coefficients (ICC) were calculated for all QoL measures, in order to assess the proportion of variance due 
to the grouping structure on country-level. ICC’s indicated a significant proportion of variance that could 
be assigned to the countries. Variation in HADS-A and HADS-D scores amounted to 5.70% and 5.37% 
respectively. For EQ-5D and EQ-VAS, ICC values of 4.92% and 8.26% were observed respectively. Country 
grouping explained 8.44% and 5.67% in the variation of PCS-12 and MCS-12 scores respectively. 
[insert table 2  somewhere here] 
Reliability 
The overall Cronbach’s alpha for the EQ-5D self-classifier equals 0.73, indicating an acceptable internal 
consistency of the measure (see table 3). The variation between countries ranged between 0.58 and 0.82. 
Ten countries had a value < 0.70, indicating less acceptable internal reliability. The SF-12 subscales had 
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higher Cronbach’s alpha values with an overall value of 0.87 and 0.84 for PCS-12 and MCS-12 
respectively. Country-specific values for PCS-12 ranged between 0.81 and 0.90, indicating good to 
excellent internal consistency. For MCS-12, Cronbach’s alpha values ranged between 0.74 and 0.89, 
indicating acceptable to good internal consistency. In addition, for both HADS-scales satisfying values 
were found overall, with a value of 0.82 and 0.74 for HADS-A and HADS-D respectively. For HADS-A 
Cronbach’s alpha ranged between 0.73 and 0.86, for HADS-D, values fluctuated between 0.52 and 0.82, 
with only 2 countries (Germany and Latvia) having a value <0.7. 
[insert table 3 somewhere here] 
Validity 
CFA of the HADS 2-factor model suggested a good construct validity with the observed data fitting well 
with the theoretical model. The Bentler’s CFI, TLI and RMSEA (0.96, 0.96 and 0.06 respectively), indicated 
a good fit and factor loadings >0.55 were found, representing a good correlation between observed 
variables and extracted components. The CFA of the SF-12 allowed for covariations between the error of 
the items that belong to one overall question (2a and 2b; 3a and 3b; 4a and 4b; 6a, 6b and 6c). Again, 
Bentler’s CFI, TLI and RMSEA indices indicated acceptable to good fit (0.98, 0.98 and 0.09 resp.) and good 
correlation between observed variables and extracted components was seen with factor loadings 
ranging between 0.55 and 0.83. 
Known-group discriminative validity analyses confirmed that all QoL measures distinguished well 
between patient groups with a different age, gender or educational level (Table 2).  Male patients had 
significantly lower HADS-A and HADS-D scores, and higher EQ-5Dindex, EQ-VAS, PCS-12 and MSC-12 scores 
compared to females. Significant differences for all measures were found between all three educational 
levels, with lower Qol values in lower educated patients. Higher anxiety, lower depression, higher EQ-
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5Dindex, EQ-VAS, PCS-12 and MCS-12 were found in younger patients compared to the older ones. On 
country-specific level, the above reported results were roughly similar. 
A correlation matrix for the different constructs or items can be found in Table 4. All theoretically 
hypothesized correlations were confirmed. There was a strong correlation among the mental health 
scores HADS-A, HADS-D and MCS-12. Also the overall health score EQ-5Dindex correlated strongly with 
PCS-12 and moderately with MCS-12. Criterion validity was confirmed for PCS-12, MCS-12 and EQ-5Dindex 
given the correlations with EQ-VAS as criterion for overall health perception. Likewise, EQ-5Dindex and EQ-
VAS showed good correlations with the overall health criterion SF12-1. Both HADS-A and HADS-D 
correlated moderate to strong with the individual mental health items EQ-5D anxiety/depression and 
SF12-6c.  
[insert table 4 somewhere here] 
Discussion 
Psychometric evaluations of the HADS, EQ-5D and SF12-v2 measures were performed in this study. Our 
study has the advantage that it comprises data on 8,745 coronary patients, spread over 22 European 
countries. This is, to our knowledge the largest study assessing the psychometric aspects of 3 different 
QoL questionnaires in a coronary population. Patients included were stable coronary patients, suffering 
from an event 6 months to 3 years prior to the interview. Data collection was organized in a standardized 
way by trained research staff, making the data suitable to compare across patients and countries. Coding 
of the data and data analyses were performed in a systematic way. Previous studies often included 
analyses on only 1 single measure and in 1 specific region or country (14;15;33-35). 
Overall, favorable results were found, supporting the use of these QoL measures in a European coronary 
population. Internal consistency was confirmed for all the QoL measures with good to excellent 
Cronbach’s alpha values for the PCS-12 scale, and moderate to good values for the MCS-12 scale and 
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both HADS-scales, across all 22 countries. EQ-5D Cronbach’s alpha values were somewhat lower with 
about half of the countries having a value slightly below 0.70, this is possibly due to the heterogeneity of 
the questionnaire. In addition, the Cronbach’s alpha is sensitive to the number of items, with a tendency 
to have a smaller value for scales with a limited number of items (36).  
A good construct validity was shown for HADS and SF12v2. For both HADS and SF-12 the TLI and CFI 
showed good fit. The RMSEA showed good fit  for HADS and a borderline acceptable fit for SF12. In 
addition, high factor loadings were observed, indicating a good correlation between observed variables 
and extracted components for both measures. 
Discriminative validity of all the QoL measures was confirmed. Higher QoL values as well as lower 
depression and anxiety scores were observed in men compared to women. These results support the 
findings previously reported in the literature (8;37-41). Likewise, in agreement with published papers, 
our study confirmed QoL differences between groups with different educational levels, with higher EQ-
VAS, PCS-12 and MCS-12 scores among higher educated ones (34). As expected anxiety and depression 
scores were higher for the lower educated ones. In addition, it was shown that across all groups, age 
significantly influenced the perceived QoL. In general, younger persons had a higher anxiety score but a 
lower depression score. This is in line with the results reported by Spinhoven et al. (1997) (42).  Likewise, 
Hinz et al. (2011) reported similar results, with lower anxiety scores for older patients (39). In contrast, 
as confirmed in the literature, older patients had lower EQ-5Dindex, EQ-VAS, PCS-12 and MCS-12 scores 
(37;40). 
Convergent validity was supported by the correlations found between the different constructs for which 
an association was theoretically expected. Moderate to strong correlations were observed between the 
SF-12 constructs and the EQ-5Dindex and EQ-VAS scores. Strengths were similar to the ones reported by 
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Johnson and Pickard (2000) (40). Likewise a strong correlation was seen among both HADS-scales and 
MCS-12. 
The strong correlation between SF12-1 and both the EQ-5Dindex and EQ-VAS confirmed good criterion 
validity for EQ-5Dindex and EQ-VAS. A similar correlation was seen in 2 previously published papers (33;35). 
Furthermore the EQ-VAS correlates well with the EQ-5Dindex and PCS-12 and moderate with MCS-12. 
Correlations reported by Ellis et al. (2005), between EQ-VAS and the physical and mental component of 
SF-8 (a derivate from SF-36) were slightly higher (0.77 and 0.55 resp.) (33). The EQ-5Dindex anxiety 
component and the SF12-6c as criterion for anxiety and depression, correlated well with both HADS-
scales.  
The main limitation of the EUROASPIRE study is its cross-sectional design, making it impossible to 
compare QoL outcomes over a given period of time and to test responsiveness and test-retest reliability. 
In addition patients are not a representative sample of all patients with CHD in each country, since they 
were identified from selected geographical areas and cardiac centers (Kotseva 2009). 
While the EQ-5D gives an overall view on a person’s general health, the SF-12v2 clearly distinguishes 
between mental and physical health. Both measures can be used at any given time, whereas HADS is 
intended for use in the hospital setting, useful in screening for anxiety and depressive feelings in patients. 
In order to have an in-depth insight in a patient’s QoL, it is advised to use a combination of general (e.g. 
EQ-5D, SF-12v2), domain specific (e.g. HADS) and disease specific (e.g. McNew, Seatle Angina 
Questionnaire) QoL measures, and not to restrict to the use of a single instrument. The integrated 
HeartQol, a coronary heart disease-specific, health-related QoL questionnaire, might be a good 
alternative (43). 
In conclusion, the results observed in our study confirm the validity and reliability of the EQ-5D, the SF-
12v2 and the HADS for use in a stable coronary population, both on aggregate European level as on 
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country-specific level. However, our results must be generalized with caution, because EUROASPIRE III 
patients might not be representative for all patients with stable coronary heart disease. 
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Table 1: Patient characteristics of the EUROASPIRE population 
 Number 
of 
patients 
Gender 
(%male) 
Age  
(mean ±SD) 
Education level 
Primary 
education (%) 
Secondary 
education (%) 
High 
education (%) 
All Countries 8745 74.6 63.2±9.5 25.3 56.7 18.0 
Belgium 281 85.4 62.4±8.8 16.3 61.6 22.1 
Bulgaria 538 69.5 64.8±10.4 3.6 63.1 33.3 
Cyprus 434 87.3 61.1±9.3 41.3 42.1 16.6 
Czech Rep. 475 79.2 62.9±8.6 3.0 80.3 16.7 
Germany 550 79.3 63.7±9.1 6.4 80.0 13.6 
Spain 505 74.7 62.0±9.7 70.3 23.9 5.8 
Finland 237 66.7 66.2±9.9 17.7 76.4 5.9 
France 303 78.3 62.2±10.4 44.9 45.9 9.2 
UK 322 73.6 63.0±9.8 8.5 66.3 25.2 
Greece 120 88.3 62.4±9.6 33.3 37.5 29.2 
Croatia 450 77.1 61.2±9.3 22.9 60.7 16.4 
Hungary 457 58.0 63.8±8.5 23.9 49.6 26.5 
Ireland 385 76.9 62.5±9.6 59.7 34.8 5.5 
Italy 377 79.3 65.2±9.1 39.9 53.2 6.9 
Lithuania 509 77.8 63.0±8.8 8.5 60.8 30.7 
Latvia 519 65.7 66.2±8.4 17.6 60.2 22.2 
Netherlands 223 81.6 64.8±8.9 26.3 67.2 6.5 
Poland 502 69.9 62.6±8.8 32.3 50.0 17.7 
Romania 521 72.6 61.7±9.8 10.4 74.4 15.2 
Russia 409 64.3 64.9±10.1 7.8 54.1 38.1 
Slovenia 293 73.0 64.8±9.7 32.1 57.7 10.2 
Turkey 335 80.6 59.8±10.1 56.7 31.4 11.9 
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Table 2: Mean values of the QoL constructs 
 HADS-A  HADS-D  EQ-5Dindex EQ-VAS PCS-12 MCS-12 
All Countries 5.93 5.08 0.76 65.66 42.14 49.15 
Belgium 5.91 4.99 0.82 72.53 45.13 49.25 
Bulgaria 6.74 5.92 0.77 63.26 42.16 50.31 
Cyprus 4.68 3.68 0.81 69.97 47.49 52.85 
Czech Rep. 4.59 4.89 0.76 65.40 41.41 49.58 
Germany 5.29 5.64 0.76 67.66 42.47 51.37 
Spain 7.09 5.29 0.73 66.75 39.39 46.42 
Finland 4.87 4.32 0.78 74.03 38.01 53.62 
France 6.59 5.61 0.71 66.66 41.63 44.42 
UK 6.16 4.47 0.71 73.34 41.93 49.36 
Greece 6.44 4.90 0.80 68.85 46.51 50.82 
Croatia 6.64 5.22 0.73 63.74 41.21 48.21 
Hungary 6.66 5.45 0.70 66.30 - - 
Ireland 5.64 3.26 0.81 73.60 45.37 51.91 
Italy 5.10 4.23 0.86 75.08 47.08 51.43 
Lithuania 6.03 4.85 0.74 58.93 38.70 48.69 
Latvia 4.30 4.65 0.84 55.52 43.93 50.42 
Netherlands 4.28 3.40 0.85 75.74 47.08 52.77 
Poland 7.21 5.65 0.73 60.75 38.78 46.37 
Romania 5.78 4.86 0.75 69.32 41.13 49.39 
Russia 7.18 6.67 0.65 59.51 36.74 45.85 
Slovenia 7.01 6.49 0.66 62.93 40.21 46.91 
Turkey 5.96 6.01 0.77 69.13 45.73 44.08 
Significance * * * * * * 
Gender       
Men 5.48 4.75 0.78 67.85 43.20 49.93 
Women 7.24 6.01 0.69 62.22 38.82 46.75 
Significance * * * * * * 
Age       
<50 year 6.35 4.42 0.81 71.43 45.59 48.84 
50-59 years 6.12 4.73 0.77 67.48 43.31 48.94 
60-69 years 5.71 5.05 0.76 66.72 42.16 49.57 
>70 years 5.89 5.70 0.72 63.03 39.56 48.90 
Significance * * * * * * 
Education level       
Primary education 6.55 5.61 0.72 64.87 40.95 47.98 
Secondary education 5.85 5.04 0.76 66.44 41.95 49.27 
High education 5.31 4.40 0.80 68.32 44.28 50.44 
Significance * * * * * * 
*  Kruskall Wallis p value <0.0001 
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Table 3: Internal consistency 
Cronbach's alpha  
  EQ-5D index SF-12 PCS SF-12 MCS HADS-A HADS-D 
All Countries 0.73 0.87 0.84 0.82 0.74 
Belgium 0.68 0.88 0.87 0.77 0.80 
Bulgaria 0.76 0.90 0.88 0.84 0.78 
Cyprus 0.67 0.85 0.84 0.83 0.77 
Czech Rep. 0.68 0.85 0.79 0.84 0.78 
Germany 0.67 -  -  0.80 0.52 
Spain 0.72 0.84 0.87 0.81 0.82 
Finland 0.67 0.88 0.82 0.77 0.72 
France 0.67 0.86 0.87 0.83 0.77 
UK 0.80 0.89 0.87 0.86 0.82 
Greece 0.75 0.86 0.89 0.79 0.76 
Croatia 0.75 0.87 0.84 0.82 0.77 
Hungary 0.71 -  -  0.84 0.80 
Ireland 0.67 0.86 0.80 0.81 0.72 
Italy 0.76 0.89 0.89 0.77 0.75 
Lithuania 0.66 0.87 0.80 0.77 0.70 
Latvia 0.58 0.84 0.74 0.73 0.62 
Netherlands 0.68 0.87 0.85 0.80 0.77 
Poland 0.73 0.84 0.82 0.82 0.72 
Romania 0.73 0.81 0.81 0.85 0.76 
Russia 0.74 0.88 0.85 0.79 0.70 
Slovenia 0.80 0.84 0.89 0.80 0.74 
Turkey 0.82 0.87 0.81 0.84 0.81 
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Table 4: Correlation between domains 
 HADS-D EQ-5Dindex EQ-5D anx/depr EQVAS PCS-12 MCS-12 SF12-1 SF12-6c 
HADS-A 0.60(0.36 to 0.73) -0.51(-0.31 to -0.61) 0.57(0.24 to 0.67) -0.36(-0.13 to -0.53) -0.34(-0.16 to -0.47) -0.59(-0.31 to -0.71) 0.36(0.11 to 0.52) -0.58 (-0.32 to -0.70) 
HADS-D  -0.51(-0.22 to -0.63) 0.45(0.24 to 0.56) -0.45(-0.14 to -0.57) -0.41(-0.13 to -0.56) -0.57(-0.22 to -0.69) 0.44(0.26 to 0.56) -0.51(-0.13 to -0.63) 
EQ-5Dindex   -0.62(-0.44 to -0.81) 0.53(0.34 to 0.97) 0.64(0.48 to 0.72) 0.47(0.20 to 0.61) -0.51(-0.33 to -0.63) 0.50(0.32 to 0.56) 
EQ-5D anx/depr    -0.34(-0.25 to -0.42) -0.26(-0.10 to -0.39) -0.54(-0.42 to -0.63) 0.31(0.16 to 0.46) -0.55(-0.47 to -0.66) 
EQVS     0.55(0.35 to 0.67) 0.41(0.23 to 0.57) -0.60(-0.48 to -0.73) 0.38(0.24 to 0.47) 
PCS-12      0.19(-0.14 to 0.44) -0.68(-0.51 to -0.75) 0.29(0.07 to 0.35) 
MCS-12       -0.38(-0.15 to -0.57) 0.76(0.63 to 0.86) 
SF12-1        -0.38(-0.24 to -0.47) 
EQ-5D anx/depr: EQ-5D Anxiety/Depression 
All correlations are significant (p< 0.05)  
 
